FLGT insider transaction filings
Fulgent Genetics, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-03. Screen FLGT transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 11 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 4 filings by 2 insiders — 5,932 shares, $117,132 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 2,127 shares @ $19.66 ($41,809) by Xie Jian, filed 2026-09-03.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Xie Jian — President and COO | 3 | — | 2 legs · 3,320 sh · $65,556 | 1 |
| Gao Hanlin — Chief Scientific Officer | 3 | — | 2 legs · 2,612 sh · $51,576 | 1 |
| Kim Paul — CFO and Treasurer | 3 | — | — | 3 |
| Hsieh Ming — Chief Executive Officer, Director, 10% owner | 2 | — | — | 2 |
Recent Form 4 filings — Fulgent Genetics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | Xie Jian — President and COO | Sale (S): 2,127 @ $19.66 | EDGAR |
| 2026-09-03 | 4 | Gao Hanlin — Chief Scientific Officer | Sale (S): 1,673 @ $19.66 | EDGAR |
| 2026-09-03 | 4 | Hsieh Ming — Chief Executive Officer, Director, 10% owner | Tax withholding (F): 4,392 @ $19.59 | EDGAR |
| 2026-09-03 | 4 | Kim Paul — CFO and Treasurer | Tax withholding (F): 2,087 @ $19.59 | EDGAR |
| 2026-08-28 | 4 | Xie Jian — President and COO | Sale (S): 1,193 @ $19.91 | EDGAR |
| 2026-08-28 | 4 | Kim Paul — CFO and Treasurer | Tax withholding (F): 1,168 @ $19.81 | EDGAR |
| 2026-08-28 | 4 | Hsieh Ming — Chief Executive Officer, Director, 10% owner | Tax withholding (F): 2,949 @ $19.81 | EDGAR |
| 2026-08-28 | 4 | Gao Hanlin — Chief Scientific Officer | Sale (S): 939 @ $19.91 | EDGAR |
| 2026-07-28 | 4 | Gao Hanlin — Chief Scientific Officer | Tax withholding (F): 1,645 @ $19.67 | EDGAR |
| 2026-07-28 | 4 | Xie Jian — President and COO | Tax withholding (F): 4,361 @ $19.67 | EDGAR |
| 2026-07-28 | 4 | Kim Paul — CFO and Treasurer | Tax withholding (F): 2,747 @ $19.67 | EDGAR |
| 2026-06-03 | 4 | Xie Jian — President and COO | Sale (S): 2,146 @ $17.89 | EDGAR |
| 2026-06-03 | 4 | Gao Hanlin — Chief Scientific Officer | Sale (S): 1,688 @ $17.89 | EDGAR |
| 2026-06-03 | 4 | Hsieh Ming — Chief Executive Officer, Director, 10% owner | Tax withholding (F): 4,392 @ $18.09 | EDGAR |
| 2026-06-03 | 4 | Kim Paul — CFO and Treasurer | Tax withholding (F): 2,087 @ $18.09 | EDGAR |
| 2026-05-28 | 4 | Xie Jian — President and COO | Sale (S): 1,201 @ $17.60 | EDGAR |
| 2026-05-28 | 4 | Gao Hanlin — Chief Scientific Officer | Sale (S): 945 @ $17.60 | EDGAR |
| 2026-05-28 | 4 | Kim Paul — CFO and Treasurer | Tax withholding (F): 1,168 @ $17.67 | EDGAR |
| 2026-05-27 | 4 | Hsieh Ming — Chief Executive Officer, Director, 10% owner | Tax withholding (F): 2,949 @ $17.67 | EDGAR |
| 2026-05-18 | 4 | Nohaile Michael — Director | Grant/award (A): 5,558 @ $0 · Grant/award (A): 8,426 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Dong Linda — Director | Grant/award (A): 11,117 @ $0 | EDGAR |
| 2026-05-18 | 4 | GROVES REGINA E — Director | Grant/award (A): 11,117 @ $0 | EDGAR |
| 2026-04-28 | 4 | Gao Hanlin — Chief Scientific Officer | Tax withholding (F): 1,645 @ $16.31 | EDGAR |
| 2026-04-28 | 4 | Xie Jian — President and COO | Tax withholding (F): 4,361 @ $16.31 | EDGAR |
| 2026-04-28 | 4 | Kim Paul — CFO and Treasurer | Tax withholding (F): 2,747 @ $16.31 | EDGAR |
| 2026-03-31 | 4/A | Hsieh Ming — Chief Executive Officer, Director, 10% owner Ming Hsieh Trust — 10% owner | Other (J): 750,000 (derivative) | EDGAR |
| 2026-03-11 | 4 | Hsieh Ming — Chief Executive Officer, Director, 10% owner | Other (J): 750,000 (derivative) | EDGAR |
| 2026-03-02 | 4 | Xie Jian — President and COO | Tax withholding (F): 1,140 @ $24.76 · Tax withholding (F): 1,079 @ $15.33 · Tax withholding (F): 8,147 @ $15.33 | EDGAR |
| 2026-03-02 | 4 | Gao Hanlin — Chief Scientific Officer | Tax withholding (F): 897 @ $24.76 · Tax withholding (F): 1,018 @ $15.33 · Tax withholding (F): 6,410 @ $15.33 | EDGAR |
| 2026-03-02 | 4 | Hsieh Ming — Chief Executive Officer, Director, 10% owner | Tax withholding (F): 2,949 @ $24.76 · Tax withholding (F): 17,566 @ $15.33 | EDGAR |
| 2026-03-02 | 4 | Kim Paul — CFO and Treasurer | Tax withholding (F): 1,168 @ $24.76 · Tax withholding (F): 1,133 @ $15.33 · Tax withholding (F): 8,347 @ $15.33 | EDGAR |
| 2026-02-25 | 4 | Xie Jian — President and COO | Tax withholding (F): 655 @ $23.01 · Grant/award (A): 5,862 @ $0 · Grant/award (A): 15,299 @ $0 · Grant/award (A): 27,341 @ $0 · Tax withholding (F): 3,163 @ $23.09 · Tax withholding (F): 8,254 @ $23.09 · +2 more | EDGAR |
| 2026-02-25 | 4 | Gao Hanlin — Chief Scientific Officer | Tax withholding (F): 403 @ $23.01 · Grant/award (A): 4,891 @ $0 · Grant/award (A): 12,762 @ $0 · Grant/award (A): 22,806 @ $0 · Tax withholding (F): 2,489 @ $23.09 · Tax withholding (F): 4,661 @ $23.09 · +2 more | EDGAR |
| 2026-02-25 | 4 | Hsieh Ming — Chief Executive Officer, Director, 10% owner | Tax withholding (F): 2,167 @ $23.01 · Grant/award (A): 19,067 @ $0 · Grant/award (A): 39,802 @ $0 · Grant/award (A): 59,276 @ $0 · Tax withholding (F): 10,230 @ $23.09 · Tax withholding (F): 21,354 @ $23.09 · +2 more | EDGAR |
| 2026-02-25 | 4 | Kim Paul — CFO and Treasurer | Tax withholding (F): 661 @ $23.01 · Grant/award (A): 5,721 @ $0 · Grant/award (A): 14,926 @ $0 · Grant/award (A): 26,673 @ $0 · Tax withholding (F): 3,241 @ $23.09 · Tax withholding (F): 8,456 @ $23.09 · +2 more | EDGAR |
| 2026-01-28 | 4 | Gao Hanlin — Chief Scientific Officer | Tax withholding (F): 1,331 @ $27.53 | EDGAR |
| 2026-01-28 | 4 | Xie Jian — President and COO | Tax withholding (F): 4,711 @ $27.53 | EDGAR |
| 2026-01-28 | 4 | Kim Paul — CFO and Treasurer | Tax withholding (F): 3,004 @ $27.53 | EDGAR |
| 2025-12-03 | 4 | Xie Jian — President and COO | Sale (S): 1,140 @ $28.33 | EDGAR |
| 2025-12-03 | 4 | Gao Hanlin — Chief Scientific Officer | Sale (S): 1,075 @ $28.33 | EDGAR |
| 2025-12-03 | 4 | Kim Paul — CFO and Treasurer | Tax withholding (F): 1,131 @ $28.52 | EDGAR |
| 2025-12-01 | 4 | Xie Jian — President and COO | Sale (S): 1,198 @ $29.57 | EDGAR |
| 2025-12-01 | 4 | Gao Hanlin — Chief Scientific Officer | Sale (S): 943 @ $29.57 | EDGAR |
| 2025-12-01 | 4 | Hsieh Ming — Chief Executive Officer, Director, 10% owner | Tax withholding (F): 2,944 @ $30.15 | EDGAR |
| 2025-12-01 | 4 | Kim Paul — CFO and Treasurer | Tax withholding (F): 1,166 @ $30.15 | EDGAR |
| 2025-11-25 | 4 | Xie Jian — President and COO | Sale (S): 681 @ $30.47 | EDGAR |
| 2025-11-25 | 4 | Gao Hanlin — Chief Scientific Officer | Sale (S): 535 @ $30.47 | EDGAR |
| 2025-11-25 | 4 | Hsieh Ming — Chief Executive Officer, Director, 10% owner | Tax withholding (F): 2,116 @ $30 | EDGAR |
| 2025-11-25 | 4 | Kim Paul — CFO and Treasurer | Tax withholding (F): 671 @ $30 | EDGAR |
| 2025-11-21 | 4 | Xie Jian — President and COO | Sale (S): 10,000 @ $29.10 · Gift (G): 10,000 @ $0 | EDGAR |
Recent 8-K events — Fulgent Genetics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-30 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-02 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-21 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-01 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-17 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-27 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-07 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-20 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=FLGT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →